Fight disinformation. Get a daily recap of the facts that matter. Sign up for the free Mother Jones newsletter.


The newest drug import from Canada may soon have pharmaceutical companies wishing for the good old days when all they had to worry about was busloads of Minnesotans nipping over the border to buy their Lipitor. Adbusters, the Vancouver-based magazine and culture jammer, has announced plans to sell an antidepressant with a centuries-long track record, minimal side effects, and a cost of mere pennies a dose. The remedy? A sugar pill, with huge built-in name recognition: Placebo. “Placebo performs comparably to, and sometimes better than, antidepressants in clinical trials,” says Richard DeGrandpre, Adbusters‘ editor. Or more bluntly: “The psychiatric drug industry is a sham.”

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you'll agree is worth supporting.

payment methods

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you’ll agree is worth supporting.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate